Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT transplant complications working party
We investigated the incidence and outcome of anti-CD19 chimeric antigen receptor (CAR) T-cells-associated Common Terminology Criteria for Adverse Events (CTCAE) ≥grade 3 cytopenia. ...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
April 18, 2023
|
| In: |
Journal for ImmunoTherapy of Cancer
Year: 2023, Jahrgang: 11, Heft: 4, Pages: 1-8 |
| ISSN: | 2051-1426 |
| DOI: | 10.1136/jitc-2022-006406 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1136/jitc-2022-006406 Verlag, kostenfrei, Volltext: https://jitc.bmj.com/content/11/4/e006406 |
| Verfasserangaben: | Olaf Penack, Christophe Peczynski, Christian Koenecke, Emmanuelle Polge, Andrea Kuhnl, Nathalie Fegueux, Michael Daskalakis, Nicolaus Kröger, Peter Dreger, Caroline Besley, Urs Schanz, Adrian Bloor, Arnold Ganser, Edouard Forcade, Lucia López Corral, Jakob R. Passweg, Urban Novak, Ivan Moiseev, Hélène Schoemans, Grzegorz W. Basak, Christian Chabannon, Anna Sureda, Dina Averbuch, Bertram Glass, Rafael de la Camara, Zinaida Peric |
| Zusammenfassung: | We investigated the incidence and outcome of anti-CD19 chimeric antigen receptor (CAR) T-cells-associated Common Terminology Criteria for Adverse Events (CTCAE) ≥grade 3 cytopenia. ... |
|---|---|
| Beschreibung: | Gesehen am 05.12.2023 |
| Beschreibung: | Online Resource |
| ISSN: | 2051-1426 |
| DOI: | 10.1136/jitc-2022-006406 |